sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks 2-phenylpiperazine

2-phenylpiperazine

CAS No.:
5271-26-1
Catalog Number:
AG003HVQ
Molecular Formula:
C10H14N2
Molecular Weight:
162.2316
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
95%
In Stock USA
United States
$50
- +
5g
95%
In Stock USA
United States
$200
- +
25g
95%
In Stock USA
United States
$800
- +
100g
95%
In Stock USA
United States
$2250
- +
Product Description
Catalog Number:
AG003HVQ
Chemical Name:
2-phenylpiperazine
CAS Number:
5271-26-1
Molecular Formula:
C10H14N2
Molecular Weight:
162.2316
MDL Number:
MFCD01871362
IUPAC Name:
2-phenylpiperazine
InChI:
InChI=1S/C10H14N2/c1-2-4-9(5-3-1)10-8-11-6-7-12-10/h1-5,10-12H,6-8H2
InChI Key:
RIMRLBGNCLMSNH-UHFFFAOYSA-N
SMILES:
N1CCNC(C1)c1ccccc1
NSC Number:
70392
Properties
Complexity:
130  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
162.116g/mol
Formal Charge:
0
Heavy Atom Count:
12  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
162.236g/mol
Monoisotopic Mass:
162.116g/mol
Rotatable Bond Count:
1  
Topological Polar Surface Area:
24.1A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
0.7  
Literature
Title Journal
Development and characterization of endocannabinoid hydrolases FAAH and MAGL inhibitors bearing a benzotriazol-1-yl carboxamide scaffold. Bioorganic & medicinal chemistry 20121101
Novel 4-phenylpiperidine-2,6-dione derivatives. Ligands for α₁-adrenoceptor subtypes. European journal of medicinal chemistry 20110701
Synthesis and Biological Evaluation of New 3-Phenyl-1-[(4-arylpiperazin-1-yl)alkyl]-piperidine-2,6-diones. Scientia pharmaceutica 20110101
Design, synthesis and pharmacological evaluation of new 1-[3-(4-arylpiperazin-1-yl)-2-hydroxy-propyl]-3,3-diphenylpyrrolidin-2-one derivatives with antiarrhythmic, antihypertensive, and alpha-adrenolytic activity. European journal of medicinal chemistry 20091001
Discovery process and pharmacological characterization of 2-(S)-(4-fluoro-2-methylphenyl)piperazine-1-carboxylic acid [1-(R)-(3,5-bis-trifluoromethylphenyl)ethyl]methylamide (vestipitant) as a potent, selective, and orally active NK1 receptor antagonist. Journal of medicinal chemistry 20090528
Aminocyclohexylsulfonamides: discovery of metabolically stable alpha(1a/1d)-selective adrenergic receptor antagonists for the treatment of benign prostatic hyperplasia/lower urinary tract symptoms (BPH/LUTS). Bioorganic & medicinal chemistry letters 20071115
Properties